share_log

美诺华(603538.SH):与默沙东合作是小分子化学合成项目

Ningbo Menovo Pharmaceutical (603538.SH): Cooperation with Merck on small molecule chemical synthesis project.

Gelonghui Finance ·  Aug 14, 2024 18:33

Ningbo Menovo Pharmaceutical (603538.SH) stated on the investor platform that the company's collaboration with Merck is a small molecule chemical synthesis project. In addition, the company's products such as Pravastatin and Atorvastatin use enzyme catalysis technology related to synthetic biology, and the GLP-1 delivery system project developed in cooperation with the University of Michigan is a synthetic biology project.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment